Literature DB >> 17311827

Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass.

Lisa de las Fuentes1, Angela L Brown, Santhosh J Mathews, Alan D Waggoner, Pablo F Soto, Robert J Gropler, Víctor G Dávila-Román.   

Abstract

AIM: To characterize the extent to which metabolic syndrome criteria predict left ventricular (LV) structure and function. METHODS AND
RESULTS: Metabolic syndrome criteria were assessed in 607 adults with normal LV function. The cohort was grouped according to the number of criteria satisfied: (1) Absent (0 criteria, n = 110); (2) Pre-Metabolic Syndrome (1-2 criteria, n = 311); and (3) Metabolic Syndrome (>or=3 criteria, n = 186). Echocardiography was used to assess LV structure (LV mass) and systolic (LVEF, Vs) and diastolic function, by pulse-wave Doppler (E/A ratio) and tissue Doppler imaging (Ve). LV volumes and LVEF were similar between groups. However, LV mass increased significantly and progressively (LVM/Ht(2.7), in g/m(2.7): 34.9 +/- 6.7, 41.0 +/- 9.5, 46.3 +/- 11.0, P < 0.001); LV relaxation decreased progressively (Ve(global'), in cm/s: 13.5 +/- 2.8, 12.1 +/- 3.0, 10.5 +/- 2.2, P < 0.001) from Absent to Pre-Metabolic Syndrome to Metabolic Syndrome groups, respectively. Multiple variable analyses showed that diastolic blood pressure, waist circumference, and triglyceride levels were independent predictors of Ve after adjustment for LV mass.
CONCLUSION: Patients with metabolic syndrome have LV diastolic dysfunction independent of LV mass. These functional abnormalities may partially explain the increased cardiovascular morbidity and mortality associated with metabolic syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17311827     DOI: 10.1093/eurheartj/ehl526

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  60 in total

1.  Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.

Authors:  Annayya R Aroor; James R Sowers; Shawn B Bender; Ravi Nistala; Mona Garro; Irina Mugerfeld; Melvin R Hayden; Megan S Johnson; Muhammad Salam; Adam Whaley-Connell; Vincent G Demarco
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

2.  Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals.

Authors:  Yi-Chih Wang; Chang-Seng Liang; Deepa M Gopal; Nir Ayalon; Courtney Donohue; Rajalakshmi Santhanakrishnan; Harpaul Sandhu; Alejandro J Perez; Jill Downing; Noyan Gokce; Wilson S Colucci; Jennifer E Ho
Journal:  Circ Heart Fail       Date:  2015-07-14       Impact factor: 8.790

Review 3.  Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis.

Authors:  H von Bibra; M St John Sutton
Journal:  Diabetologia       Date:  2010-03-30       Impact factor: 10.122

Review 4.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

5.  Impact of diabetes in patients with pulmonary hypertension.

Authors:  Abraham D Abernethy; Kathryn Stackhouse; Stephen Hart; Ganesh Devendra; Thomas M Bashore; Raed Dweik; Richard A Krasuski
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

6.  Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis.

Authors:  Zi-Lun Li; John R Woollard; Behzad Ebrahimi; John A Crane; Kyra L Jordan; Amir Lerman; Shen-Ming Wang; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

Review 7.  Molecular determinants of the cardiometabolic phenotype.

Authors:  Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

8.  Dietary pattern, the metabolic syndrome, and left ventricular mass and systolic function: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Longjian Liu; Jennifer A Nettleton; Alain G Bertoni; David A Bluemke; João A Lima; Moyses Szklo
Journal:  Am J Clin Nutr       Date:  2009-06-10       Impact factor: 7.045

9.  Association of the metabolic syndrome with pulmonary venous hypertension.

Authors:  Ivan M Robbins; John H Newman; Roger F Johnson; Anna R Hemnes; Richard D Fremont; Robert N Piana; David X Zhao; Daniel W Byrne
Journal:  Chest       Date:  2009-02-02       Impact factor: 9.410

10.  Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function.

Authors:  Jyh-Ming Jimmy Juang; Lisa de Las Fuentes; Alan D Waggoner; C Charles Gu; Víctor G Dávila-Román
Journal:  BMC Med Genet       Date:  2010-04-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.